2024 Q3 Form 10-Q Financial Statement

#000168316824005366 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $100.6M $90.38M
YoY Change 9.23% 6.51%
Cost Of Revenue $50.06M $46.71M
YoY Change 32.07% 30.82%
Gross Profit $45.02M $43.67M
YoY Change -6.59% -11.15%
Gross Profit Margin 44.76% 48.32%
Selling, General & Admin $19.00M $36.99M
YoY Change 3.4% 12.31%
% of Gross Profit 42.2% 84.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $214.0K $221.0K
YoY Change 7.54% 4.74%
% of Gross Profit 0.48% 0.51%
Operating Expenses $93.73M $42.50M
YoY Change 20.38% 39.12%
Operating Profit -$48.71M $1.172M
YoY Change 64.21% -93.7%
Interest Expense $50.06M $5.500M
YoY Change 32.11%
% of Operating Profit 469.28%
Other Income/Expense, Net
YoY Change
Pretax Income $6.851M $6.672M
YoY Change -51.81% -64.14%
Income Tax $2.055M $2.000M
% Of Pretax Income 30.0% 29.98%
Net Earnings $4.796M $4.672M
YoY Change -53.79% -66.52%
Net Earnings / Revenue 4.77% 5.17%
Basic Earnings Per Share $0.22 $0.22
Diluted Earnings Per Share $0.20 $0.19
COMMON SHARES
Basic Shares Outstanding 21.33M shares 21.02M shares
Diluted Shares Outstanding 24.15M shares 24.26M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.071M $9.752M
YoY Change -2.76% 37.72%
Cash & Equivalents $8.071M $9.752M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $7.788M $12.03M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.86M $21.78M
YoY Change -62.77% -59.24%
LONG-TERM ASSETS
Property, Plant & Equipment $1.078M $1.192M
YoY Change -16.76% -7.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $40.90M $259.3M
YoY Change 57.96% 66.81%
Total Long-Term Assets $3.447B $3.265B
YoY Change 21.44% 16.58%
TOTAL ASSETS
Total Short-Term Assets $15.86M $21.78M
Total Long-Term Assets $3.447B $3.265B
Total Assets $3.463B $3.287B
YoY Change 20.2% 15.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $49.68M $66.39M
YoY Change -14.34% 15.7%
Accrued Expenses $22.60M $23.23M
YoY Change 438.12% 340.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $72.28M $66.39M
YoY Change 16.21% 15.7%
LONG-TERM LIABILITIES
Long-Term Debt $3.105B $2.940B
YoY Change 21.65% 15.68%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.105B $2.940B
YoY Change 21.65% 15.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $72.28M $66.39M
Total Long-Term Liabilities $3.105B $2.940B
Total Liabilities $3.178B $3.006B
YoY Change 21.52% 15.68%
SHAREHOLDERS EQUITY
Retained Earnings $261.9M $257.1M
YoY Change 8.83% 11.65%
Common Stock $25.04M $25.06M
YoY Change -11.37% -10.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $285.1M $280.3M
YoY Change
Total Liabilities & Shareholders Equity $3.463B $3.287B
YoY Change 20.2% 15.16%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $4.796M $4.672M
YoY Change -53.79% -66.52%
Depreciation, Depletion And Amortization $214.0K $221.0K
YoY Change 7.54% 4.74%
Cash From Operating Activities $69.76M $43.29M
YoY Change 13.99% -22.03%
INVESTING ACTIVITIES
Capital Expenditures $100.0K $145.0K
YoY Change -50.0% 353.13%
Acquisitions
YoY Change
Other Investing Activities -$218.9M -$209.0M
YoY Change 165.36% 190.87%
Cash From Investing Activities -$219.0M -$209.2M
YoY Change 164.83% 190.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 161.7M 281.5M
YoY Change 1848.16% 11434.21%
NET CHANGE
Cash From Operating Activities 69.76M 43.29M
Cash From Investing Activities -219.0M -209.2M
Cash From Financing Activities 161.7M 281.5M
Net Change In Cash 12.44M 115.7M
YoY Change -194.25% -929.73%
FREE CASH FLOW
Cash From Operating Activities $69.76M $43.29M
Capital Expenditures $100.0K $145.0K
Free Cash Flow $69.66M $43.15M
YoY Change 14.2% -22.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6487000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5127000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8125000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6062000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29700000 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
26800000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6200000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13300000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2894000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z9yjw1tyiei8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_860_zUFmCDJXmWFc">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on net income or shareholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2024Q2 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
12714000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
27553000 usd
CY2024Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
442000 usd
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1100000 usd
CY2024Q2 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
12714000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
27553000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1890000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
14728000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2869000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
21753000 usd
CY2024Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1950000 usd
CY2023Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-9700000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-3585000 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-18700000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
431000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1897000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1432000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
4914000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1175000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2590000 usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
2832000 usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
7582000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
684000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5721000 usd
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
684000 usd
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5721000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
431000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1897000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1432000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4914000 usd
CY2024Q2 cpss Gross Balance Of Repossessions In Inventory
GrossBalanceOfRepossessionsInInventory
435000 usd
CY2023Q4 cpss Gross Balance Of Repossessions In Inventory
GrossBalanceOfRepossessionsInInventory
597000 usd
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-371000 usd
CY2023 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-472000 usd
CY2024Q2 us-gaap Foreclosed Assets
ForeclosedAssets
64000 usd
CY2023Q4 us-gaap Foreclosed Assets
ForeclosedAssets
125000 usd
cpss Final Scheduled Payment Date
FinalScheduledPaymentDate
CY2024Q2 cpss Receivables Pledged
ReceivablesPledged
3006726000 usd
CY2024Q2 cpss Securitization Trust Debt Initial Principal
SecuritizationTrustDebtInitialPrincipal
6255048000 usd
CY2024Q2 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
2753447000 usd
CY2023Q4 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
2280021000 usd
CY2024Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
17200000 usd
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
14600000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
256900000 usd
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
206321000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
301813000 usd
CY2024Q1 cpss Securitization Of Residual Interests
SecuritizationOfResidualInterests
50000000 usd
CY2024Q1 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
50000000 usd
CY2024Q2 cpss Securitization Of Residual Interests Outstanding
SecuritizationOfResidualInterestsOutstanding
50000000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
921000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
125000 usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1782000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
4378000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
4119000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
9040000 usd
CY2024Q2 us-gaap Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
85099000 usd
CY2023Q2 us-gaap Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
76735000 usd
us-gaap Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
165604000 usd
us-gaap Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
150793000 usd
CY2024Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1486000 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1524000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2932000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2866000 usd
CY2024Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
88367000 usd
CY2023Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
82637000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
172655000 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
162699000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
46710000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
35706000 usd
us-gaap Interest Expense
InterestExpense
88678000 usd
us-gaap Interest Expense
InterestExpense
68465000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21263000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20866000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21203000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20643000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3000000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
4507000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3230000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
4741000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24263000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25373000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24433000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25384000 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1700000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1500000 shares
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2400000 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2400000 usd
CY2024Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2000000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30 pure
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4700000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9300000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25 pure
CY2023Q3 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1100000 usd
CY2024Q2 cpss Probable Legal Contingencies
ProbableLegalContingencies
2300000 usd
CY2024Q2 cpss Maximum Possible Losses For Legal Proceedings And Contingencies
MaximumPossibleLossesForLegalProceedingsAndContingencies
4300000 usd
CY2024Q1 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2791373000 usd
CY2023Q1 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2575117000 usd
CY2023Q4 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2722662000 usd
CY2022Q4 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2476617000 usd
CY2024Q2 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
424867000 usd
CY2023Q2 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
305450000 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
753760000 usd
us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
658048000 usd
CY2024Q2 cpss Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
-208964000 usd
CY2023Q2 cpss Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
-215314000 usd
cpss Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
-419899000 usd
cpss Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
-421940000 usd
CY2024Q2 cpss Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
52401000 usd
CY2023Q2 cpss Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
46833000 usd
cpss Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
106648000 usd
cpss Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
94305000 usd
CY2024Q2 cpss Mark To Fair Value
MarkToFairValue
5500000 usd
CY2023Q2 cpss Mark To Fair Value
MarkToFairValue
0 usd
cpss Mark To Fair Value
MarkToFairValue
10500000 usd
cpss Mark To Fair Value
MarkToFairValue
0 usd
CY2024Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2960375000 usd
CY2023Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2618420000 usd
CY2024Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2960375000 usd
CY2023Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2618420000 usd
CY2024Q2 cpss Finance Receivables Contractual Balance
FinanceReceivablesContractualBalance
3160134000 usd
CY2024Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2960375000 usd
CY2023Q4 cpss Finance Receivables Contractual Balance
FinanceReceivablesContractualBalance
2941915000 usd
CY2023Q4 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2722662000 usd
CY2024Q2 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2960375000 usd
CY2023Q4 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
2722662000 usd
cpss Discount Rate On Finance Receivables
DiscountRateOnFinanceReceivables
11.39%
CY2023 cpss Discount Rate On Finance Receivables
DiscountRateOnFinanceReceivables
11.35%
cpss Cumulative Net Losses On Finance Receivables
CumulativeNetLossesOnFinanceReceivables
15.38%
CY2023 cpss Cumulative Net Losses On Finance Receivables
CumulativeNetLossesOnFinanceReceivables
15.25%
CY2024Q2 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
3160134000 usd
CY2023Q4 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
2941915000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9752000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
256859000 usd
CY2024Q2 cpss Finance Receivables Fair Value Disclosure
FinanceReceivablesFairValueDisclosure
10326000 usd
CY2024Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
129000 usd
CY2024Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
82175000 usd
CY2024Q2 cpss Residuals Interest Financing
ResidualsInterestFinancing
99079000 usd
CY2024Q2 us-gaap Accounts Payable Fair Value Disclosure
AccountsPayableFairValueDisclosure
8473000 usd
CY2024Q2 us-gaap Secured Debt
SecuredDebt
2711060000 usd
CY2024Q2 us-gaap Subordinated Debt
SubordinatedDebt
22356000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6174000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
119257000 usd
CY2023Q4 cpss Finance Receivables Fair Value Disclosure
FinanceReceivablesFairValueDisclosure
20848000 usd
CY2023Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
292000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
234025000 usd
CY2023Q4 us-gaap Accounts Payable Fair Value Disclosure
AccountsPayableFairValueDisclosure
7928000 usd
CY2023Q4 us-gaap Secured Debt
SecuredDebt
2183331000 usd
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
17188000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-005366-index-headers.html Edgar Link pending
0001683168-24-005366-index.html Edgar Link pending
0001683168-24-005366.txt Edgar Link pending
0001683168-24-005366-xbrl.zip Edgar Link pending
cpss-20240630.xsd Edgar Link pending
cps_ex3101.htm Edgar Link pending
cps_ex3102.htm Edgar Link pending
cps_ex3200.htm Edgar Link pending
cps_i10q-063024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
cpss-20240630_lab.xml Edgar Link unprocessable
cpss-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cps_i10q-063024_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cpss-20240630_cal.xml Edgar Link unprocessable
cpss-20240630_def.xml Edgar Link unprocessable